lifestyle.thedailyhaze.com

Author: Beyond Air™

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

April 20, 2026
Beyond Air to Participate in the D. Boral Capital Global Conference 2026

April 15, 2026
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)

April 1, 2026
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

March 17, 2026
Beyond Air to Participate in the 38th Annual Roth Conference in March

March 11, 2026
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.

March 10, 2026
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

February 20, 2026
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

February 17, 2026
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026

February 11, 2026
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

January 27, 2026